Few FDA-cleared AI tools exist for pediatric neuroimaging despite adult neuroradiology dominance

Most FDA-cleared AI tools for radiology are in neuroradiology, but very few for pediatrics. Children’s limited exam tolerance, small datasets, and normal age-related variability are cited as barriers.

• The vast majority of FDA-cleared AI software for radiology targets neuroradiology, yet pediatric neuroradiology applications remain scarce.
• Pediatric AI lags due to limited exam tolerance, small and rare datasets, and age-related variability in normal and pathological findings.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.